IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
about
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemiaDiagnosis and subclassification of acute lymphoblastic leukemiaRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineCIViC databaseChildhood acute lymphoblastic leukemia: Integrating genomics into therapyPharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyTumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.Childhood B-acute lymphoblastic leukemia: a genetic update.Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04Ikaros deficiency in host hematopoietic cells separates GVL from GVHD after experimental allogeneic hematopoietic cell transplantationPrognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia.Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.Recurrent deletions of IKZF1 in pediatric acute myeloid leukemiaCorrelation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL.Characterization of leukemias with ETV6-ABL1 fusionDeregulation of DUX4 and ERG in acute lymphoblastic leukemia.A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network.Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL.Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome.Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.Novel therapy for childhood acute lymphoblastic leukemia.Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia.Interphase FISH for BCR-ABL1 rearrangement on neutrophils: A decisive tool to discriminate a lymphoid blast crisis of chronic myeloid leukemia from a de novo BCR-ABL1 positive acute lymphoblastic leukemia.Combination of IKZF1 deletion and early molecular response show significant roles on prognostic stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia patients.Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis.Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index < 1.16.
P2860
Q26749177-40FA567F-F8F9-4915-A8C8-7C2EC9854748Q26824387-061379AF-F208-4B6E-80B8-46FD8794BA32Q26864460-4410B795-1D15-42EA-81EE-9D10EFC259D8Q27612411-104A33B0-05AE-4978-8855-CE570376D6EEQ28080463-B1BE3674-F2F6-470B-BA17-6846B9F61A5EQ28083449-1E76A288-BA41-493F-B1F5-483EE8DA9286Q33573735-D47475DA-745E-4C5B-A5DE-1579DE9B381EQ33777616-9A3DF133-0716-4E88-9777-1BFFCD6461D3Q35602127-B0C98FD6-D8CE-4717-9C18-6F0B54E38A14Q35799360-F20D72CE-3FBD-4ADC-806D-01FDC4CFD9DEQ35986474-2672C3A4-A081-4079-9121-00E90B2197CDQ36070567-872F840F-6F8D-4347-A502-272B7DFD1D89Q36709009-B49BB10E-A56E-4BEB-AECE-ADBB638C9F89Q36811503-D5507406-96A2-405B-805C-03B74C772FBEQ36833021-83FAE8FC-01FE-4128-9905-BBF7EB00C187Q37331221-B288CB8F-BB60-44D1-B54D-8AE9ED4C8FB1Q37483972-2851F741-66D5-483E-9882-1EC9C7F82788Q37507603-0AD44867-E6C0-4D28-BD76-4DF33753AA47Q37619813-D2631E07-B8E2-4E16-919D-FFB31F982E5CQ38264774-5D7BC1A1-AD17-4168-B7E0-0C9E155B1225Q38381463-6BD2613F-E1A3-4ECD-A97C-607A83821580Q38492313-C0388059-556A-4278-B0B9-11405C8F951BQ38698520-819D4042-4464-416C-B3E5-464B3A910D93Q38716763-8160FA7B-1BCB-4E4F-A0AB-0334B8734789Q38841153-81DE2A04-FC38-49BD-8FEC-3916B2EAA054Q39014321-BB109423-AC87-4951-9CBE-ABC3F3280535Q39368957-9D2AFAE5-8B39-4E14-B8D3-790660001B01Q39751939-E0091502-F8C3-42A5-B1A7-8C719B476A87Q39985910-BCB06B41-C988-491C-BFEF-7C453D64A7D6Q41000106-E0379900-1483-4584-8FB5-7B0DA14DA81FQ41556401-1F06C788-04F5-4A30-B560-8BD3D184795EQ41688725-6A64B87E-82C6-4FCC-9E38-7686DB78C8B4Q41697696-65C2708A-3585-42CA-A50D-C6014A1EDE2AQ42368324-6348D1A7-A03F-4C2F-BC30-28DEAE203B2FQ46112819-40E0FE50-8A8D-4EE1-A689-CF038E8BA575Q48231057-71BB1F93-E42C-4D00-B36B-B44609651D74Q50038847-C24EB59D-902B-4498-AAB9-41FE550218A0Q51343198-5A4B7E44-0432-4F5B-A29B-7214ECC27585Q52717677-BBF0D082-579B-44BF-A9A8-7DAB01051822Q52870427-3D08CDD2-8D0E-4E22-965A-7F62203FB726
P2860
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@ast
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@en
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@nl
type
label
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@ast
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@en
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@nl
prefLabel
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@ast
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@en
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@nl
P2093
P50
P3181
P1433
P1476
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.
@en
P2093
Andrea Biondi
Arian van der Veer
Federica Mottadelli
Gertruuy Te Kronnie
Giovanni Cazzaniga
Maria Grazia Valsecchi
Marketa Zaliova
Paola De Lorenzo
P304
P3181
P356
10.1182/BLOOD-2013-06-509794
P407
P50
P577
2014-03-13T00:00:00Z